BioNTech SE (BNTX)
328.35
+15.76 +5.04%
NASDAQ
Jul 30, 20:00
USD
View All Key Stats
Key Stats
| Income Statement | |
| Revenue (TTM) | 3.005B |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (TTM) | 5.714 |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Net Income (TTM) | 1.454B |
| Profitability | |
| Gross Profit Margin (Quarterly) | 88.62% |
| Profit Margin (Quarterly) | 55.07% |
| Dividend | |
| Dividend Yield (Forward) | Upgrade |
| Dividend Yield | 0.00% |
| Price and Valuation | |
| Market Cap | 79.30B |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| PS Ratio | 27.95 |
| PE Ratio | 57.46 |
| Price to Book Value | 47.00 |
| Other | |
| Beta (5Y) | Upgrade |
| Debt to Equity Ratio | -- |
| Free Cash Flow (Quarterly) | -- |
| Return on Equity | Upgrade |
View All BNTX News
News
-
WireHeadlineTime (ET)
-
Yahoo07/31 13:25
-
Yahoo07/31 08:02
-
SA Breaking News07/30 16:49
-
Yahoo07/30 13:56
-
Yahoo07/30 13:34
-
Yahoo07/30 12:31
-
Yahoo07/30 06:02
-
SA Breaking News07/30 04:12
-
Yahoo07/29 17:56
-
Yahoo07/29 14:27
-
Yahoo07/29 14:06
-
Yahoo07/29 10:32
-
Yahoo07/29 06:39
-
Yahoo07/29 06:00
-
Yahoo07/28 18:41
-
Yahoo07/28 15:45
-
Yahoo07/28 15:26
-
Yahoo07/28 14:21
-
Yahoo07/28 13:51
-
SA Breaking News07/28 13:21
View All Events
Events
| Date | Type | Description |
|---|---|---|
| 08/11/2021 | Earnings Results | Q2 2021 Earnings Results |
| 08/11/2021 | Earnings Calls | Q2 2021 Earnings Call |
| 06/22/2021 08:00 EST | AGM | 2020 Annual General Meeting |
| 05/10/2021 | Earnings Results | Q1 2021 Earnings Results |
| 05/10/2021 08:00 EST | Earnings Calls | Q1 2021 Earnings Call |
| 03/30/2021 | Earnings Results | Q4 2020 Earnings Results |
| 03/30/2021 08:00 EST | Earnings Calls | Q4 2020 Earnings Call |
| 11/10/2020 | Earnings Results | Q3 2020 Earnings Results |
| 11/10/2020 | Earnings Calls | Q3 2020 Earnings Call |
| 08/11/2020 | Earnings Results | Q2 2020 Earnings Results |
Fundamentals
Income Statement View Statement
Ratings & Reports
- Y-Rating Upgrade
- Value Score Upgrade
- Fundamental Score Upgrade
- Valuation (Hist. Mult.) Upgrade
- Y-Rating Report Download
- One Page Report Download
Advertisement
Edit
Profile
- Description: BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including COVID-19. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies; cell therapies; bispecific antibodies; and small-molecule immunomodulators. BioNTech is partnered with several large pharmaceutical companies, including Roche, Eli Lilly, Pfizer, Sanofi, and Genmab. Comirnaty (COVID-19 vaccine) is its first commercialized product.
- URL: https://www.biontech.de
- Investor Relations URL: https://investors.biontech.de/
- HQ State/Province: N/A
- Sector: Healthcare
- Industry: Biotechnology
- Equity Style: N/A
- Next Earnings Release: Aug. 11, 2021
- Last Earnings Release: May. 10, 2021
- Next Ex-Dividend Date: N/A
- Last Ex-Dividend Date: N/A
Analyst Coverage
| Consensus Recommendations | |
| Buy Recommendations | Upgrade |
| Outperform Recommendations | Upgrade |
| Hold Recommendations | Upgrade |
| Underperform Recommendations | Upgrade |
| Sell Recommendations | Upgrade |
| Consensus Recommendation | Upgrade |
| Consensus Rating | Upgrade |
| Target Price | |
| Price | 328.35 |
| Price Target | Upgrade |
| Price Target Upside (Daily) | Upgrade |
Top Fund Holders
| Symbol | Name | Weighting |
|---|---|---|
| AADR | AdvisorShares Dorsey Wright ADR ETF | 6.25% |
| BBH | VanEck Vectors Biotech ETF | 5.81% |
| IDNA | iShares Genomics Immnlgy & Hlthcr ETF | 5.34% |
| FBT | First Trust NYSE Arca Biotech ETF | 4.42% |
| IBB | iShares Biotechnology ETF | 4.13% |
| BFGFX | Baron Focused Growth Retail | 3.52% |
| DYN1523 | Dynamic Power Global Growth Class Sr OP | 3.32% |
| FPXI | First Trust International Eq Opps ETF | 2.54% |
| VHCOX | Vanguard Capital Opportunity Inv | 2.30% |
| PJHRX | PGIM Jennison Health Sciences R | 1.87% |
| THISX | T. Rowe Price Health Sciences I | 1.84% |
| POAGX | PRIMECAP Odyssey Aggressive Growth | 1.79% |
Other Resources
- 13F Filings Whale Wisdom
- Call Transcripts Seeking Alpha
- Insider Trading Morningstar
- Institutional Ownership Nasdaq
- SEC Filings SEC
- BNTX Tweets Stocktwits
Advertisement
